Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stress Prevention and Stress Management Techniques IV

Stress Prevention and Stress Management Techniques IV

Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...

Chronic Obstructive Pulmonary Disease II: Emphysema

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.

Chronic Pancreatitis II: Pathophysiology

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...

CNS Depressants: Alcohol and Nicotine

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hepatitis C virus induced insulin resistance impairs response to anti viral therapy.

World journal of gastroenterology·2012

Same author

Apelin serum level in Egyptian patients with chronic hepatitis C.

Mediators of inflammation·2011

Same author

Characterization of chronic HCV infection-induced apoptosis.

Comparative hepatology·2011

Same author

Effect of surveillance for hepatocellular carcinoma on tumor staging and treatment decisions in Egyptian patients.

Hepatology international·2010

Same author

Hepatitis C comorbidities affecting the course and response to therapy.

World journal of gastroenterology·2009

Same author

Evaluation of liver biopsy in Egyptian HBeAg-negative chronic hepatitis B patients at initial presentation: implications for therapy.

The American journal of gastroenterology·2009

Search research articles

Related Experiment Video

Updated: Jul 19, 2026

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

Heavy smoking and liver.

Abdel-Rahman El-Zayadi¹

¹Hepatology and Gastroenterology, Ain Shams University and Director of Cairo Liver Center. 5, El-Gergawy St. Dokki, Giza, Egypt. clcz@tedata.net.eg

World Journal of Gastroenterology

|October 13, 2006

Summary

Smoking harms the liver through toxic, immunological, and oncogenic effects, increasing risks for liver injury, fibrosis, and cancer. It also contributes to iron overload and impacts immune responses and cancer surveillance.

Area of Science:

Hepatology
Toxicology
Immunology

Background:

Smoking induces direct and indirect toxic effects on the liver, increasing necroinflammation and fibrosis.
It elevates pro-inflammatory cytokines (IL-1, IL-6, TNF-α), contributing to liver cell injury.
Smoking promotes secondary polycythemia, leading to iron overload and oxidative stress in hepatocytes.

Discussion:

Smoking impairs both cell-mediated and humoral immune responses, affecting lymphocyte proliferation and inducing apoptosis.
Increased serum and hepatic iron levels due to smoking exacerbate oxidative stress and lipid peroxidation, activating hepatic stellate cells and promoting fibrosis.
Oncogenic chemicals in tobacco smoke increase hepatocellular carcinoma (HCC) risk, independent of viral hepatitis, and suppress the p53 tumor suppressor gene.

Key Insights:

More Related Videos

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface

Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface

Published on: February 21, 2011

Related Experiment Videos

Last Updated: Jul 19, 2026

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface

Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface

Published on: February 21, 2011

Tobacco smoking significantly elevates the risk of liver fibrosis and hepatocellular carcinoma (HCC).
Smoking-induced iron overload and oxidative stress are critical mechanisms driving liver damage and cancer development.
Impaired immune surveillance and T-cell responses in smokers contribute to reduced tumor cell detection.

Outlook:

Understanding these mechanisms can inform targeted interventions for liver disease prevention in smokers.
Further research into the specific oncogenic pathways activated by smoking is warranted.
Strategies to mitigate smoking-related liver damage, including managing iron overload and enhancing immune function, may improve patient outcomes, particularly in those with viral hepatitis.